Global Biomarkers Report 2017 Dublin, Nov. 06, 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
50
Global Biomarkers Report 2017

Dublin, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.

Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics.

Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine.

Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed.

Biomarker markets are estimated from 2016 to 2026 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed.

A large number of companies with varying technical backgrounds are involved in biomarkers and 302 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 466 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 910 references, 80 tables and 22 figures.

Key Topics Covered:

Part 1: Technologies & Applications Executive Summary 1. Introduction 2. Technologies for Discovery of Biomarkers 3. Biomarkers and Molecular Diagnostics 4. Biomarkers for Drug Discovery & Development 5. Role of Biomarkers in Healthcare 6. Biomarkers in Metabolic Disorders 7. Biomarkers in Immune Disorders 8. Biomarkers of Musculoskeletal Disorders 9. Biomarkers of Infectious Diseases 10. Biomarkers of Genetic Disorders 11. Biomarkers of Aging 12. Nutritional Biomarkers 13. Biomarkers of Cancer 14. Biomarkers of Disorders of the Nervous System 15. Biomarkers of Cardiovascular Disorders 16. Biomarkers of Pulmonary Diseases 17. Biomarkers in Gynecology and Obstetrics 18. Biomarkers & Personalized Medicine 19. Biomarkers and Regulatory issues 20. References Part II: Markets & Companies 21. Markets for Biomarkers 22. Companies

For more information about this report visit https://www.researchandmarkets.com/research/h...biomarkers

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomarkers

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Award Recognizes Global Banking Innovation 2026

Updated Category News Views 55

Championing Banking Innovations Globally If there's one thing you can count on in the financial world, it's innovation pushing the boundaries of how we bank. The 13th edition of the Qorus-Infosys Finacle Banking Innovation Awards has once again proven that innovation is not just a buzzword but a real, transformative force in the global banking landscape. This year, they...

Continue Reading
5W Lauded by Inc.'s Power Partner Awards in 2026

Updated Category News Views 72

5W's Ascent in the PR World Who'd have thought a PR firm would bask in the limelight like this? 5W, a key player in the public relations jungle, is bagging recognition from Inc.'s Power Partner Awards this year. These awards aren't handed out like free samples; they're a shoutout to those who truly matter to businesses aiming for the stars. A Powerhouse of Visibility and...

Continue Reading
Coffee Bean Brews Up Nostalgia with Tiramisu Treats

Updated Category News Views 124

Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...

Continue Reading
MUFG Debuts VAM for Streamlined Treasury Ops

Updated Category News Views 0

MUFG's Bold Move into Digital Liquidity Alright, let's dive into MUFG's latest shake-up, and boy, it's no small fry. This Japanese financial giant's got its eyes set on transforming how businesses handle their cash with what they're calling Virtual Account Management, or VAM - a fancy name for a digital liquidity tool that's looking to cut the clutter of multiple bank...

Continue Reading
Marc Ryan Joins ABCS Insights as Chief Product Officer

Updated Category News Views 16

Shaping the Future of Advertising Effectiveness In the ever-evolving ad measurement arena, where understanding what works can make or break a company, ABCS Insights has tossed a game-changing hat into the ring. They've just announced Marc Ryan as their new Chief Product Officer. Now, I’ve seen seasoned execs shuffle seats countless times, but this one’s...

Continue Reading
LG Energy Sparks Global Innovation with BIC 2026

Updated Category News Views 54

Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 81

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
Meritus Health Adopts Sectra's Cloud for Radiology Boost

Updated Category News Views 24

Meritus' Bold Move into the Cloud Jumping headlong into the tech game, Meritus Health has teamed up with Sectra to harness their One Cloud solution. This isn't just a plug-and-play deal; it's a strategic bet to overhaul how radiology is done. Do you know the kind of back-and-forth it takes to get a diagnostic image these days? Too much, if you ask me. Meritus is going...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 24

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
EDB Enhances Postgres with Horizontal Scaling Preview

Updated Category News Views 6

EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...

Continue Reading

Top 5 Most Recently Viewed Articles

PennantPark Investment Corporation Reveals October Dividend Plans

Updated Category News Views 128

PennantPark Investment Corporation's Monthly Distribution Announcement On the fruitful journey of investing, PennantPark Investment Corporation has declared a notable monthly distribution of $0.08 per share for October. This decision reflects the company's commitment to provide value to its stockholders. The payment is set to occur on a date that ensures all stockholders...

Continue Reading
LevelBlue Launches Security Services to Boost MSSPs and MSPs Growth

Updated Category News Views 66

Enhancing Security Offerings for MSSPs and MSPs In an effort to bolster the capabilities of Managed Security Service Providers (MSSPs) and Managed Service Providers (MSPs), LevelBlue, a leading provider of managed network security services, recently introduced four innovative security services at the prestigious MSSP Alert Live event. These new offerings are designed to...

Continue Reading
Aurora Cannabis Achieves EU-GMP Certification, Expanding Reach

Updated Category News Views 193

Aurora Cannabis Achieves EU-GMP Certification for Distribution Centre Aurora Cannabis Inc. (NASDAQ: ACB) is excited to announce a significant milestone with the certification of its dedicated distribution centre under European Union Good Manufacturing Practice (EU-GMP) standards. This notable achievement not only solidifies Aurora's position within the global medical...

Continue Reading
Solving Unstable Internet Issues for Buffalo Businesses

Updated Category News Views 7

Internet Woes: More Than Meets the Eye You're neck-deep in an important video call, and BAM! The internet drops out like a bad habit. Sound familiar? While you'd love to blame your service provider, there’s a sneaky saboteur in the mix—your very own network setup. Richard Hermann of TC Technologies sheds some light on why Buffalo businesses often face this ugly issue...

Continue Reading
CelluPro Earns Global Recognition with EXCiPACT Certification

Updated Category News Views 14

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

Continue Reading